Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine after liver resection for HBV-related hepatocellular carcinoma
ACTRN12614001224617Phase 4Active, not recruiting
- Sponsor
- ZHOU Wei-ping
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telbivudine, sponsored by ZHOU Wei-ping. Started Apr 2012; status: active, not recruiting.
02
Drugs
telbivudine
Beyond the preview
Go deeper on ACTRN12614001224617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001224617.